AGP Executive Report
Last update: a few seconds agoLocal Health Tech & Care Access: Implantica’s RefluxStop® update from Liechtenstein highlights Q2 growth and safety follow-up, plus FDA PMA approval that opens the U.S. market and expands European “Centers of Excellence” to 60+ sites. Transplant Breakthrough: Hansa Biopharma reports Australia’s first commercial living-donor kidney transplant using Idefirix (imlifidase) for highly sensitised patients, aiming to improve access when cross-matches are hard. Royal Health Watch: Norway’s King Harald V was admitted to hospital for fluid accumulation after cortisone treatment for hemolytic anaemia; his son will act as regent during a two-week sick leave. Digital Health & Privacy Risk: A France tax-data breach is raising impersonation concerns, with attackers reportedly using detailed income and withholding information to sound like genuine tax officials—an indirect warning for scams that can hit health-related households too. Policy & Mobility: EU foreign policy moves to align eight non-EU countries, including Liechtenstein, with Belarus sanctions—relevant for cross-border compliance and public services.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
